CY1120447T1 - Συνθεσεις παραγοντα καθαρισμου και μεθοδοι για τη χρηση του - Google Patents

Συνθεσεις παραγοντα καθαρισμου και μεθοδοι για τη χρηση του

Info

Publication number
CY1120447T1
CY1120447T1 CY20181100401T CY181100401T CY1120447T1 CY 1120447 T1 CY1120447 T1 CY 1120447T1 CY 20181100401 T CY20181100401 T CY 20181100401T CY 181100401 T CY181100401 T CY 181100401T CY 1120447 T1 CY1120447 T1 CY 1120447T1
Authority
CY
Cyprus
Prior art keywords
methods
present
composition cleaning
cleaning factors
cleaning
Prior art date
Application number
CY20181100401T
Other languages
English (en)
Inventor
Jeffrey P. Gilbard
Yanick Douyon
Robert B. Huson
Original Assignee
Advanced Vision Research, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Vision Research, Inc. filed Critical Advanced Vision Research, Inc.
Publication of CY1120447T1 publication Critical patent/CY1120447T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά αντιμικροβιακές συνθέσεις παράγοντα καθαρισμού που περιέχουν λιναλοόλη, ινοκιτιόλη και διπροπυλενογλυκόλη. Η παρούσα εφεύρεση παρέχει περαιτέρω μεθόδους για τη χρήση αυτών των συνθέσεων για τη διατήρηση της υγιεινής του βλεφάρου, για τη θεραπεία οφθαλμικής διαταραχής ή για τον καθαρισμό της επιφάνειας του δέρματος. Οι συνθέσεις του παράγοντα καθαρισμού της παρούσας εφεύρεσης μπορεί να έχουν τη μορφή αφρού, γέλης ή υγρού.
CY20181100401T 2009-05-01 2018-04-17 Συνθεσεις παραγοντα καθαρισμου και μεθοδοι για τη χρηση του CY1120447T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17462809P 2009-05-01 2009-05-01
PCT/US2010/033140 WO2010127227A1 (en) 2009-05-01 2010-04-30 Cleanser compositions and methods for using the same

Publications (1)

Publication Number Publication Date
CY1120447T1 true CY1120447T1 (el) 2019-07-10

Family

ID=43032577

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100401T CY1120447T1 (el) 2009-05-01 2018-04-17 Συνθεσεις παραγοντα καθαρισμου και μεθοδοι για τη χρηση του

Country Status (13)

Country Link
US (7) US8231912B2 (el)
EP (2) EP3363425A1 (el)
AU (1) AU2010242866B2 (el)
CA (1) CA2760591C (el)
CY (1) CY1120447T1 (el)
DK (1) DK2424374T3 (el)
ES (1) ES2666174T3 (el)
LT (1) LT2424374T (el)
NO (1) NO2424374T3 (el)
NZ (1) NZ596254A (el)
PL (1) PL2424374T3 (el)
PT (1) PT2424374T (el)
WO (1) WO2010127227A1 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127227A1 (en) 2009-05-01 2010-11-04 Advanced Vision Research, Inc. Cleanser compositions and methods for using the same
US9161923B2 (en) 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
JP5952302B2 (ja) * 2010-12-29 2016-07-13 ニチャミン、ルイス・ディー 眼の治療のための方法及びキット
WO2013114127A1 (en) 2012-02-03 2013-08-08 Anant Sharma Eye Massage Device
EP2879492B1 (en) * 2012-08-06 2018-10-03 Isp Investments Inc. Eco-friendly non-aqueous antimicrobial composition comprising hinokitiol with 1,3-propanediol or sorbitan caprylate
DE102013223789A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223793A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102014005807A1 (de) * 2014-04-19 2015-11-19 Herbert Widulle Mittel zur Händedesinfektion ohne niedrig siedende Lösemittel wie Ethanol oder Propanol
CA2955975A1 (en) * 2014-05-28 2015-12-03 Lunovus, Llc Ocular eyelid scrub composition for the treatment of demodex blepharitis
CN104000749B (zh) * 2014-05-30 2016-09-07 纳爱斯集团有限公司 一种头皮护理液
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
EP3285729B1 (en) 2015-04-23 2019-12-18 The Procter and Gamble Company Concentrated personal cleansing compositions and methods
WO2016172472A1 (en) 2015-04-23 2016-10-27 The Procter & Gamble Company Concentrated personal cleansing compositions and uses
EP3285725B1 (en) 2015-04-23 2019-12-04 The Procter and Gamble Company Concentrated personal cleansing compositions
EP3285728B1 (en) 2015-04-23 2019-12-18 The Procter and Gamble Company Concentrated personal cleansing compositions and methods
US10688122B2 (en) 2015-09-28 2020-06-23 Azura Ophthalmics Ltd. Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
CN109310665A (zh) 2016-04-14 2019-02-05 阿祖拉眼科有限公司 用于治疗睑板腺功能障碍的二硫化硒组合物
WO2018075749A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Skin cleansing compositions and methods
US11185486B2 (en) 2016-10-21 2021-11-30 The Procter And Gamble Company Personal cleansing compositions and methods
EP3533438B1 (en) * 2016-10-28 2021-07-21 Kaneka Corporation Gelatinous composition
US10675231B2 (en) 2017-02-17 2020-06-09 The Procter & Gamble Company Packaged personal cleansing product
US10806686B2 (en) 2017-02-17 2020-10-20 The Procter And Gamble Company Packaged personal cleansing product
WO2019057899A1 (en) * 2017-09-22 2019-03-28 Lipid Systems Sp. Z.O.O. AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PHOSHOLIPID AND AT LEAST ONE TERPENE WITH ACIDICITY ACTIVITY AGAINST DEMODEX
US11191705B2 (en) 2018-09-10 2021-12-07 The Procter And Gamble Company Personal cleansing compositions
CN109316369B (zh) * 2018-09-19 2021-09-03 德国欧悦安股份有限公司 一种洁面慕斯及其制备方法
WO2021007587A1 (en) * 2019-07-05 2021-01-14 The Procter & Gamble Company Personal care cleaning compositions
WO2021140417A2 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity
EP4008335A1 (en) * 2020-12-07 2022-06-08 Susanne Vingerhoets Jensen Composition comprising melaleuca alternifolia essential oil, use and method

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527165A (en) 1978-08-18 1980-02-27 Mitsubishi Petrochem Co Ltd Novel tetrahydrofuranol derivative, its preparation and perfume containing the same
FR2526534B2 (fr) 1982-05-05 1985-08-02 Chauvet Pierre Dispositif de detentes doubles et independantes, adaptable en detente unique, selective ou non, avec mise en surete, pour fusils de chasse a canons superposes
US5009890A (en) 1987-08-10 1991-04-23 Trilling Medical Technologies, Inc. Burn treatment product
US5384125A (en) 1987-03-31 1995-01-24 Water-Jel Technologies, Inc. Burn dressing
DE69128614T2 (de) * 1990-09-14 1998-05-20 Otsuka Pharma Co Ltd Reinigungsmittelzusammensetzung
ES2132224T3 (es) * 1992-03-13 1999-08-16 Otsuka Pharma Co Ltd Procedimiento de tratamiento de enfermedades infecciosas, procedimiento que permite impedir la putrefaccion de los productos cosmeticos, y producto cosmetico y agente antibacteriano/antifungico.
RU2085204C1 (ru) 1994-07-07 1997-07-27 Макеев Борис Александрович Способ получения бальзама, обладающего ранозаживляющим действием
US5965518A (en) 1998-02-23 1999-10-12 Nakatsu; Tetsuo Fragrance compositions having antimicrobial activity
JP2000016933A (ja) * 1998-06-30 2000-01-18 Shiki:Kk アレルギー疾患の症状緩和方法
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
AUPQ632300A0 (en) 2000-03-20 2000-04-15 Boeck, Harry Bactericidal solution
JP4931286B2 (ja) 2000-05-16 2012-05-16 テイカ製薬株式会社 眼科用剤
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
EP1349558B1 (en) 2000-12-12 2011-06-15 Angiolab, Inc. Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
SK14762003A3 (sk) 2001-05-31 2004-08-03 Pharmacia Corporation Kožou prestupujúci prípravok obsahujúci selektívne inhibujúcu cyklooxygenázu-2 a jednosýtny alkohol
US6585961B1 (en) * 2001-11-30 2003-07-01 Richard F. Stockel Antimicrobial compositions
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20050158405A1 (en) 2004-01-21 2005-07-21 Alex Boukas Personal decontaminant
JP3774219B2 (ja) 2004-02-23 2006-05-10 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧品、医薬品及び食品
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060068044A1 (en) 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US20120040809A1 (en) 2010-08-11 2012-02-16 Formicola Thomas M Stretch-Out Roll Up Bar
US20070243275A1 (en) * 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
EP1964542A1 (en) * 2007-03-02 2008-09-03 Takasago International Corporation Sensitive skin perfumes
WO2010127227A1 (en) 2009-05-01 2010-11-04 Advanced Vision Research, Inc. Cleanser compositions and methods for using the same

Also Published As

Publication number Publication date
EP2424374A1 (en) 2012-03-07
AU2010242866B2 (en) 2014-09-25
LT2424374T (lt) 2018-04-25
WO2010127227A1 (en) 2010-11-04
US8449928B2 (en) 2013-05-28
NO2424374T3 (el) 2018-06-16
US20200383326A1 (en) 2020-12-10
US20160095312A1 (en) 2016-04-07
AU2010242866A1 (en) 2011-11-24
DK2424374T3 (en) 2018-05-07
CA2760591A1 (en) 2010-11-04
US20210212318A1 (en) 2021-07-15
PT2424374T (pt) 2018-04-23
US20100285155A1 (en) 2010-11-11
US20120288575A1 (en) 2012-11-15
CA2760591C (en) 2018-01-02
US20130236579A1 (en) 2013-09-12
EP2424374B1 (en) 2018-01-17
EP3363425A1 (en) 2018-08-22
US9050288B2 (en) 2015-06-09
US20150057364A1 (en) 2015-02-26
PL2424374T4 (pl) 2018-07-31
US8231912B2 (en) 2012-07-31
ES2666174T3 (es) 2018-05-03
NZ596254A (en) 2013-06-28
US8932653B2 (en) 2015-01-13
EP2424374A4 (en) 2015-07-15
PL2424374T3 (pl) 2018-07-31

Similar Documents

Publication Publication Date Title
CY1120447T1 (el) Συνθεσεις παραγοντα καθαρισμου και μεθοδοι για τη χρηση του
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
MX346352B (es) Composicion limpiadora.
PH12014500053A1 (en) Proteasome inhibitors
CR20120490A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
CR11731A (es) Composiciones y procedimientos para su preparación y uso
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
EA200701995A1 (ru) Способы уменьшения кальцификации
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
BR112015024846A2 (pt) composições para utilização no estímulo do crescimento ósseo
BR112015022408A2 (pt) barras de limpeza que compreendem copolímeros anfifílicos super-hidrofílicos, e métodos para uso das mesmas
EA201190344A1 (ru) Составы для лечения боли в глубоких тканях
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
PH12019501469A1 (en) Compositions and methods for treating biofilms
EA201400660A1 (ru) Противомикробная композиция
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
BRPI0817483A2 (pt) uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
EA201591793A1 (ru) Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний
BR112015006272A2 (pt) ''uso cosmético, composto, composição cosmética e método de tratamento cosmético''
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение